Genomics

Dataset Information

RAS-mutant AML LSCs originate from GMPs and drive clinical resistance to BH3 mimetics


ABSTRACT: RAS-mutant AML LSCs originate from GMPs and drive clinical resistance to BH3 mimetics

PROVIDER: PRJNA1066799 | ENA |

REPOSITORIES: ENA